A proposed renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) is being advocated to better reflect the condition's hormonal and metabolic impacts beyond just reproductive issues, potentially improving diagnosis and care.